These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33234672)

  • 1. Bleeding and thrombotic risk in pregnant women with Fontan physiology.
    Girnius A; Zentner D; Valente AM; Pieper PG; Economy KE; Ladouceur M; Roos-Hesselink JW; Warshak C; Partington SL; Gao Z; Ollberding N; Faust M; Girnius S; Kaemmerer H; Nagdyman N; Cohen S; Canobbio M; Akagi T; Grewal J; Bradley E; Buber Y; Palumbo J; Walker N; Aboulhosn J; Oechslin E; Baumgartner H; Kurdi W; Book WM; Mulder BJM; Veldtman GR
    Heart; 2021 Sep; 107(17):1390-1397. PubMed ID: 33234672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
    Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
    Yelnik CM; Lambert M; Drumez E; Le Guern V; Bacri JL; Guerra MM; Laskin CA; Branch DW; Sammaritano LR; Morel N; Guettrot-Imbert G; Launay D; Hachulla E; Hatron PY; Salmon JE; Costedoat-Chalumeau N
    Lupus; 2018 Sep; 27(10):1679-1686. PubMed ID: 30016929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Bates SM; Greer IA; Hirsh J; Ginsberg JS
    Chest; 2004 Sep; 126(3 Suppl):627S-644S. PubMed ID: 15383488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients.
    Faircloth JM; Miner KM; Alsaied T; Nelson N; Ciambarella J; Mizuno T; Palumbo JS; Vinks AA; Veldtman GR
    J Thromb Thrombolysis; 2017 Jul; 44(1):38-47. PubMed ID: 28429248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.
    Rodger MA; Hague WM; Kingdom J; Kahn SR; Karovitch A; Sermer M; Clement AM; Coat S; Chan WS; Said J; Rey E; Robinson S; Khurana R; Demers C; Kovacs MJ; Solymoss S; Hinshaw K; Dwyer J; Smith G; McDonald S; Newstead-Angel J; McLeod A; Khandelwal M; Silver RM; Le Gal G; Greer IA; Keely E; Rosene-Montella K; Walker M; Wells PS;
    Lancet; 2014 Nov; 384(9955):1673-83. PubMed ID: 25066248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of warfarin versus aspirin after Fontan surgery.
    Attard C; Monagle PT; d'Udekem Y; Mackay MT; Briody J; Cordina R; Hassan EB; Simm P; Rice K; Ignjatovic V;
    J Thorac Cardiovasc Surg; 2021 Oct; 162(4):1218-1228.e3. PubMed ID: 33563422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
    Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Yosuico VE; Terrenato I; Sperati F; Barba M; Hicks LK; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD014739. PubMed ID: 34582035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to guidelines for perioperative management of anticoagulation results in decreased bleeding complications: a single-centre experience.
    DeSancho MT; Bardarova S; Chapin J
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):426-9. PubMed ID: 25699609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular, obstetric and neonatal outcomes in women with previous fontan repair.
    Bonner SJ; Asghar O; Roberts A; Vause S; Clarke B; Keavney B
    Eur J Obstet Gynecol Reprod Biol; 2017 Dec; 219():53-56. PubMed ID: 29054041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves.
    Steinberg ZL; Dominguez-Islas CP; Otto CM; Stout KK; Krieger EV
    J Am Coll Cardiol; 2017 Jun; 69(22):2681-2691. PubMed ID: 28571631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes: A survey of 1075 cases from EUROAPS registry∗.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Tincani A; Pardos-Gea J; Nalli C; Marozio L; Espinosa G; De Carolis S; Latino O; Sebastian U; LLurba E; Trespidi L; Chighizola C; Pengo V; Rovere-Querini P; Canti V; Mayer-Pickel K; Reshetnyak T; Tabacco S; Arnau A;
    Eur J Anaesthesiol; 2021 Sep; 38(9):916-922. PubMed ID: 34397526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
    Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Late Thromboembolic Complications Post-Fontan Procedure in Relation to Different Antithrombotic Regimens: 30-Years' Follow-up Experience.
    Al-Jazairi AS; Al Alshaykh HA; Di Salvo G; De Vol EB; Alhalees ZY
    Ann Pharmacother; 2019 Aug; 53(8):786-793. PubMed ID: 30788973
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
    Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
    Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.
    Monagle P; Cochrane A; Roberts R; Manlhiot C; Weintraub R; Szechtman B; Hughes M; Andrew M; McCrindle BW;
    J Am Coll Cardiol; 2011 Aug; 58(6):645-51. PubMed ID: 21798429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.